Revenue
2021
2022
2023
2024
2025
Adagio Medical Holdings, Inc. (ADGM)
Price$0.5800Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0 | $269,000 | $300,000 | $189,000 | $270,000 |
| Gross profit | −$684,000 | −$1.7M | −$1.0M | −$686,000 | −$888,000 |
| Gross margin | — | −620.07% | −335.33% | −362.96% | −328.89% |
| Research & development | $10.6M | $4.6M | $15.4M | $17.9M | $15.4M |
| Operating expenses | $21.9M | $62.7M | $28.2M | $23.2M | $19.8M |
| Operating income | −$21.9M | −$62.5M | −$27.9M | −$23.9M | −$20.6M |
| Operating margin | — | −23,226.77% | −9,314.00% | −12,652.38% | −7,646.30% |
| EBITDA | −$20.9M | −$61.7M | −$27.4M | −$23.0M | −$19.6M |
| EBITDA margin | — | −22,951.67% | −9,136.67% | −12,191.01% | −7,260.00% |
| Net income | −$25.1M | −$53.8M | −$36.6M | −$23.7M | −$19.9M |
| Net profit margin | — | −19,986.25% | −12,196.67% | −12,525.40% | −7,384.44% |
| Basic EPSper basic share | -$1.51 | -$3.38 | -$48.16 | -$1.77 | -$1.49 |
| Diluted EPSper diluted share | -$1.51 | -$3.70 | -$48.16 | -$1.77 | -$1.49 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
PERCEPTIVE ADVISORS LLC / EDELMAN JOSEPH / C2 Life Sciences LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 9.88M |
BERGHEIM OLAV | 234.13K |
Usen Todd | 207.32K |
Cox James L | 36.7K |
Kaster Deborah | 15K |
Bergheim Hakon | 7.54K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 16, 2025Form 4 | Kaster DeborahChief Financial Officer | BuyCommon Stock | 15.0K | $1.20 | $18.0K | 15.0K |
| Dec 12, 2025Form 4 | Usen ToddChief Executive Officer | BuyCommon Stock | 207.3K | $1.09 | $226.0K | 207.3K |
| Oct 20, 2025Form 4 | EDELMAN JOSEPH +2TenPercentOwner | BuyPre-Funded Warrant (right to buy) · derivative · indirect | 2.19M | $1.60 | $3.50M | 2.19M |
| Oct 20, 2025Form 4 | EDELMAN JOSEPH +2TenPercentOwner | BuyTranche C Warrant ("Common Warrant" right to buy) · derivative · indirect | 1.34M | $0.18 | $242.1K | 1.34M |
| Oct 20, 2025Form 4 | EDELMAN JOSEPH +2TenPercentOwner | BuyTranche B Warrant ("Common Warrant" right to buy) · derivative · indirect | 1.34M | $0.18 | $242.1K | 1.34M |